Correlation Between Straumann Holding and Akoya Biosciences

Can any of the company-specific risk be diversified away by investing in both Straumann Holding and Akoya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Straumann Holding and Akoya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Straumann Holding AG and Akoya Biosciences, you can compare the effects of market volatilities on Straumann Holding and Akoya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Straumann Holding with a short position of Akoya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Straumann Holding and Akoya Biosciences.

Diversification Opportunities for Straumann Holding and Akoya Biosciences

0.43

Correlation Coefficient

Straumann Holding  Akoya Biosciences

Very weak diversification

The 3 months correlation between Straumann and Akoya is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Straumann Holding AG and Akoya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akoya Biosciences and Straumann Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Straumann Holding AG are associated (or correlated) with Akoya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akoya Biosciences has no effect on the direction of Straumann Holding i.e., Straumann Holding and Akoya Biosciences go up and down completely randomly.

Pair Corralation between Straumann Holding and Akoya Biosciences

Assuming the 90 days horizon Straumann Holding is expected to generate 4.75 times less return on investment than Akoya Biosciences. But when comparing it to its historical volatility, Straumann Holding AG is 2.24 times less risky than Akoya Biosciences. It trades about 0.01 of its potential returns per unit of risk. Akoya Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  221.00  in Akoya Biosciences on September 7, 2024 and sell it today you would lose (9.00) from holding Akoya Biosciences or give up 4.07% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Straumann Holding AG  vs.  Akoya Biosciences

Straumann Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Straumann Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical indicators, Straumann Holding is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Akoya Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Akoya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Akoya Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Straumann Holding and Akoya Biosciences

The main advantage of trading using opposite Straumann Holding and Akoya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Straumann Holding position performs unexpectedly, Akoya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will offset losses from the drop in Akoya Biosciences' long position.

The idea behind Straumann Holding AG and Akoya Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.